(ATRO) Astronics - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US0464331083
Stock: Aerospace, Defense, Electronics, Test
Total Rating 68
Risk 81
Buy Signal -0.66
| Risk 5d forecast | |
|---|---|
| Volatility | 60.2% |
| Relative Tail Risk | -23.9% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.99 |
| Alpha | 140.40 |
| Character TTM | |
|---|---|
| Beta | 1.190 |
| Beta Downside | 1.839 |
| Drawdowns 3y | |
|---|---|
| Max DD | 34.89% |
| CAGR/Max DD | 2.11 |
EPS (Earnings per Share)
Revenue
Risks
Fundamental:
P/E ratio: 78.9259
Description: ATRO Astronics March 04, 2026
Astronics Corporation (ATRO) designs and manufactures products for the aerospace, defense, and electronics sectors. The company operates globally, with significant presence in North America, Asia, and Europe. The aerospace and defense sector is characterized by long product development cycles and high regulatory hurdles.
The company has two primary segments: Aerospace and Test Systems. The Aerospace segment provides various aircraft components, including lighting, power generation, and avionics. This segment serves original equipment manufacturers (OEMs) and aircraft operators, including commercial airlines and military branches.
The Test Systems segment develops automated test equipment and simulation devices. This segment supports aerospace, defense, communications, and mass transit industries. Customers include OEMs and prime government contractors. The business model for test systems often involves recurring revenue from maintenance and support services.
For more detailed analysis, consider exploring ValueRays comprehensive reports on ATRO.
Headlines to watch out for
- Aerospace OEM demand dictates revenue for aircraft components
- Defense spending impacts Test Systems segment orders
- Supply chain disruptions increase manufacturing costs
- Commercial airline recovery drives cabin electronics sales
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: 29.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA 2.79 > 1.0 |
| NWC/Revenue: 34.39% < 20% (prev 33.95%; Δ 0.44% < -1%) |
| CFO/TA 0.11 > 3% & CFO 75.5m > Net Income 29.4m |
| Net Debt (360.2m) to EBITDA (66.2m): 5.44 < 3 |
| Current Ratio: 3.10 > 1.5 & < 3 |
| Outstanding Shares: last quarter (38.5m) vs 12m ago 8.70% < -2% |
| Gross Margin: 29.94% > 18% (prev 0.25%; Δ 2.97k% > 0.5%) |
| Asset Turnover: 127.2% > 50% (prev 122.6%; Δ 4.60% > 0%) |
| Interest Coverage Ratio: 3.53 > 6 (EBITDA TTM 66.2m / Interest Expense TTM 12.6m) |
Altman Z'' 4.59
| A: 0.42 (Total Current Assets 437.7m - Total Current Liabilities 141.3m) / Total Assets 706.7m |
| B: 0.31 (Retained Earnings 216.7m / Total Assets 706.7m) |
| C: 0.07 (EBIT TTM 44.3m / Avg Total Assets 677.7m) |
| D: 0.38 (Book Value of Equity 212.7m / Total Liabilities 566.6m) |
| Altman-Z'' Score: 4.59 = AA |
Beneish M -3.20
| DSRI: 0.99 (Receivables 204.7m/191.4m, Revenue 862.1m/795.4m) |
| GMI: 0.82 (GM 29.94% / 24.63%) |
| AQI: 1.01 (AQ_t 0.18 / AQ_t-1 0.18) |
| SGI: 1.08 (Revenue 862.1m / 795.4m) |
| TATA: -0.07 (NI 29.4m - CFO 75.5m) / TA 706.7m) |
| Beneish M-Score: -3.20 (Cap -4..+1) = AA |
What is the price of ATRO shares?
As of March 16, 2026, the stock is trading at USD 63.93 with a total of 1,502,891 shares traded.
Over the past week, the price has changed by -14.00%, over one month by -16.94%, over three months by +22.21% and over the past year by +156.64%.
Over the past week, the price has changed by -14.00%, over one month by -16.94%, over three months by +22.21% and over the past year by +156.64%.
Is ATRO a buy, sell or hold?
Astronics has received a consensus analysts rating of 3.33.
Therefor, it is recommend to hold ATRO.
- StrongBuy: 0
- Buy: 1
- Hold: 2
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the ATRO price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 87.6 | 37% |
| Analysts Target Price | 87.6 | 37% |
ATRO Fundamental Data Overview March 15, 2026
P/E Trailing = 78.9259
P/E Forward = 26.6667
P/S = 2.6466
P/B = 16.2895
P/EG = 1.4638
Revenue TTM = 862.1m USD
EBIT TTM = 44.3m USD
EBITDA TTM = 66.2m USD
Long Term Debt = 334.5m USD (from longTermDebt, last quarter)
Short Term Debt = 5.80m USD (from shortTermDebt, last quarter)
Debt = 378.4m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 360.2m USD (from netDebt column, last quarter)
Enterprise Value = 2.64b USD (2.28b + Debt 378.4m - CCE 18.2m)
Interest Coverage Ratio = 3.53 (Ebit TTM 44.3m / Interest Expense TTM 12.6m)
EV/FCF = 60.23x (Enterprise Value 2.64b / FCF TTM 43.9m)
FCF Yield = 1.66% (FCF TTM 43.9m / Enterprise Value 2.64b)
FCF Margin = 5.09% (FCF TTM 43.9m / Revenue TTM 862.1m)
Net Margin = 3.41% (Net Income TTM 29.4m / Revenue TTM 862.1m)
Gross Margin = 29.94% ((Revenue TTM 862.1m - Cost of Revenue TTM 604.0m) / Revenue TTM)
Gross Margin QoQ = 33.31% (prev 30.51%)
Tobins Q-Ratio = 3.74 (Enterprise Value 2.64b / Total Assets 706.7m)
Interest Expense / Debt = 0.90% (Interest Expense 3.39m / Debt 378.4m)
Taxrate = 8.15% (2.63m / 32.2m)
NOPAT = 40.7m (EBIT 44.3m * (1 - 8.15%))
Current Ratio = 3.10 (Total Current Assets 437.7m / Total Current Liabilities 141.3m)
Debt / Equity = 2.70 (Debt 378.4m / totalStockholderEquity, last quarter 140.1m)
Debt / EBITDA = 5.44 (Net Debt 360.2m / EBITDA 66.2m)
Debt / FCF = 8.21 (Net Debt 360.2m / FCF TTM 43.9m)
Total Stockholder Equity = 196.8m (last 4 quarters mean from totalStockholderEquity)
RoA = 4.33% (Net Income 29.4m / Total Assets 706.7m)
RoE = 14.92% (Net Income TTM 29.4m / Total Stockholder Equity 196.8m)
RoCE = 8.34% (EBIT 44.3m / Capital Employed (Equity 196.8m + L.T.Debt 334.5m))
RoIC = 9.17% (NOPAT 40.7m / Invested Capital 443.8m)
WACC = 8.95% (E(2.28b)/V(2.66b) * Re(10.30%) + D(378.4m)/V(2.66b) * Rd(0.90%) * (1-Tc(0.08)))
Discount Rate = 10.30% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 5.04%
[DCF] Terminal Value 66.02% ; FCFF base≈35.2m ; Y1≈23.1m ; Y5≈10.5m
[DCF] Fair Price = N/A (negative equity: EV 176.7m - Net Debt 360.2m = -183.5m; debt exceeds intrinsic value)
EPS Correlation: 77.00 | EPS CAGR: 36.29% | SUE: 0.86 | # QB: 1
Revenue Correlation: 56.03 | Revenue CAGR: 21.35% | SUE: 0.48 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.64 | Chg7d=+0.007 | Chg30d=+0.027 | Revisions Net=+3 | Analysts=4
EPS current Year (2026-12-31): EPS=2.64 | Chg7d=+0.000 | Chg30d=+0.125 | Revisions Net=+3 | Growth EPS=+31.5% | Growth Revenue=+12.7%
EPS next Year (2027-12-31): EPS=3.14 | Chg7d=+0.038 | Chg30d=+0.212 | Revisions Net=+3 | Growth EPS=+18.9% | Growth Revenue=+8.8%
[Analyst] Revisions Ratio: +1.00 (3 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 9.0% (Discount Rate 10.3% - Earnings Yield 1.3%)
[Growth] Growth Spread = +7.6% (Analyst 16.6% - Implied 9.0%)
P/E Forward = 26.6667
P/S = 2.6466
P/B = 16.2895
P/EG = 1.4638
Revenue TTM = 862.1m USD
EBIT TTM = 44.3m USD
EBITDA TTM = 66.2m USD
Long Term Debt = 334.5m USD (from longTermDebt, last quarter)
Short Term Debt = 5.80m USD (from shortTermDebt, last quarter)
Debt = 378.4m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 360.2m USD (from netDebt column, last quarter)
Enterprise Value = 2.64b USD (2.28b + Debt 378.4m - CCE 18.2m)
Interest Coverage Ratio = 3.53 (Ebit TTM 44.3m / Interest Expense TTM 12.6m)
EV/FCF = 60.23x (Enterprise Value 2.64b / FCF TTM 43.9m)
FCF Yield = 1.66% (FCF TTM 43.9m / Enterprise Value 2.64b)
FCF Margin = 5.09% (FCF TTM 43.9m / Revenue TTM 862.1m)
Net Margin = 3.41% (Net Income TTM 29.4m / Revenue TTM 862.1m)
Gross Margin = 29.94% ((Revenue TTM 862.1m - Cost of Revenue TTM 604.0m) / Revenue TTM)
Gross Margin QoQ = 33.31% (prev 30.51%)
Tobins Q-Ratio = 3.74 (Enterprise Value 2.64b / Total Assets 706.7m)
Interest Expense / Debt = 0.90% (Interest Expense 3.39m / Debt 378.4m)
Taxrate = 8.15% (2.63m / 32.2m)
NOPAT = 40.7m (EBIT 44.3m * (1 - 8.15%))
Current Ratio = 3.10 (Total Current Assets 437.7m / Total Current Liabilities 141.3m)
Debt / Equity = 2.70 (Debt 378.4m / totalStockholderEquity, last quarter 140.1m)
Debt / EBITDA = 5.44 (Net Debt 360.2m / EBITDA 66.2m)
Debt / FCF = 8.21 (Net Debt 360.2m / FCF TTM 43.9m)
Total Stockholder Equity = 196.8m (last 4 quarters mean from totalStockholderEquity)
RoA = 4.33% (Net Income 29.4m / Total Assets 706.7m)
RoE = 14.92% (Net Income TTM 29.4m / Total Stockholder Equity 196.8m)
RoCE = 8.34% (EBIT 44.3m / Capital Employed (Equity 196.8m + L.T.Debt 334.5m))
RoIC = 9.17% (NOPAT 40.7m / Invested Capital 443.8m)
WACC = 8.95% (E(2.28b)/V(2.66b) * Re(10.30%) + D(378.4m)/V(2.66b) * Rd(0.90%) * (1-Tc(0.08)))
Discount Rate = 10.30% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 5.04%
[DCF] Terminal Value 66.02% ; FCFF base≈35.2m ; Y1≈23.1m ; Y5≈10.5m
[DCF] Fair Price = N/A (negative equity: EV 176.7m - Net Debt 360.2m = -183.5m; debt exceeds intrinsic value)
EPS Correlation: 77.00 | EPS CAGR: 36.29% | SUE: 0.86 | # QB: 1
Revenue Correlation: 56.03 | Revenue CAGR: 21.35% | SUE: 0.48 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.64 | Chg7d=+0.007 | Chg30d=+0.027 | Revisions Net=+3 | Analysts=4
EPS current Year (2026-12-31): EPS=2.64 | Chg7d=+0.000 | Chg30d=+0.125 | Revisions Net=+3 | Growth EPS=+31.5% | Growth Revenue=+12.7%
EPS next Year (2027-12-31): EPS=3.14 | Chg7d=+0.038 | Chg30d=+0.212 | Revisions Net=+3 | Growth EPS=+18.9% | Growth Revenue=+8.8%
[Analyst] Revisions Ratio: +1.00 (3 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 9.0% (Discount Rate 10.3% - Earnings Yield 1.3%)
[Growth] Growth Spread = +7.6% (Analyst 16.6% - Implied 9.0%)